All stocks Β· VINRKLB
RL

Rekvina Laboratories Ltd

VINRKLB BSE Drug Manufacturers - Specialty & Generic Healthcare

Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. Rekvin…

ISIN INE092O01028
Listed β€”
Quarters tracked 13
Filings 19 docs

About

Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. Rekvina Laboratories Limited was incorporated in 1988 and is based in Vadodara, India.

Key Metrics

as of Sep 2026
Market Cap60 Cr
P/Eβ€”
Div Yield0.00 %
Book Valueβ‚Ή-1.02
52w Highβ‚Ή53.80
52w Lowβ‚Ή6.75
Face Valueβ‚Ή5.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 0.67 0.72 0.35 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.79 0.78 0.47 0.23 0.04 0.04 0.02 0.07 0.00 0.00 0.00 0.01 0.00
Operating Profit -0.12 -0.06 -0.12 -0.03 -0.04 -0.04 -0.02 -0.07 0.00 0.00 0.00 -0.01 0.00
OPM % -17.91 -8.33 -34.29 -15.00 β€” β€” β€” β€” β€” β€” β€” β€” β€”
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.12 -0.06 -0.12 -0.03 -0.04 -0.04 -0.02 -0.07 0.00 0.00 0.00 -0.01 0.00
Tax % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 β€” β€” β€” 0.00 β€”
Net Profit -0.12 -0.06 -0.12 -0.03 -0.04 -0.04 -0.02 -0.07 0.00 0.00 0.00 -0.01 0.00
EPS in Rs -0.10 -0.05 -0.10 -0.02 -0.03 -0.03 -0.02 -0.06 0.00 0.00 0.00 -0.01 0.00

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Sales 1.270.000.000.00-0.040.000.000.000.000.060.030.08
Expenses 1.520.140.020.000.040.060.150.100.050.120.030.05
Operating Profit -0.25-0.14-0.020.00-0.08-0.06-0.15-0.10-0.05-0.060.000.03
OPM % -19.69β€”β€”β€”β€”β€”β€”β€”β€”-100.000.0037.50
Other Income 0.000.000.000.000.000.000.150.020.030.000.000.00
Interest 0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation 0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax -0.25-0.14-0.020.00-0.08-0.060.00-0.08-0.02-0.060.000.03
Tax % 0.000.000.00β€”0.000.00β€”0.000.000.00β€”33.33
Net Profit -0.25-0.14-0.020.00-0.08-0.060.00-0.08-0.02-0.060.000.02
EPS in Rs -0.21-0.12-0.020.00-0.07-0.050.00-0.07-0.02-0.050.000.02
Dividend Payout % 0.000.000.00β€”0.000.00β€”0.000.000.00β€”0.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Equity Capital 3.013.013.013.013.013.013.013.013.013.013.013.01
Reserves -4.24-3.35-3.21-3.00-3.00-2.92-2.86-2.61-2.53-2.51-2.45-2.33
Borrowings 1.470.250.040.080.000.000.000.210.170.010.010.00
Other Liabilities 0.950.120.170.110.180.150.130.190.140.130.090.09
Total Liabilities 1.190.030.010.200.190.240.280.800.790.640.660.77
Fixed Assets 0.000.000.000.150.150.150.150.150.150.150.150.27
CWIP 0.000.000.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.050.050.050.050.050.050.050.050.05
Other Assets 1.190.030.010.00-0.010.040.080.600.590.440.460.45
Total Assets 1.190.030.010.200.190.240.280.800.790.640.660.77

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Cash from Operating Activity -0.59-0.19-0.010.01-0.04-0.01-0.01-0.020.01-0.04-0.02-0.01
Cash from Investing Activity 0.000.000.000.000.040.000.000.00-0.070.070.020.01
Cash from Financing Activity 0.580.210.010.000.000.000.000.040.160.000.010.00
Net Cash Flow -0.010.020.000.010.00-0.01-0.010.010.100.030.000.00
Free Cash Flow -0.59-0.19-0.010.01-0.04-0.01-0.01-0.020.01-0.04-0.02-0.01
CFO/OP % 236.00136.0050.00β€”50.0017.007.0020.00-20.0067.00β€”-33.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2023Mar 2022Mar 2021Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Debtor Days 0.00β€”0.00β€”β€”β€”1,703.333,041.671,003.75
Inventory Days 0.00β€”0.00β€”β€”β€”β€”β€”β€”
Cash Conversion Cycle 0.00β€”0.00β€”β€”β€”1,703.333,041.671,003.75
Working Capital Days -106.34β€”-1,642.50β€”β€”β€”1,460.004,015.001,460.00
ROCE % -333.330.00-160.00-50.00-12.70-3.45-11.110.004.51

Shareholding Pattern

% holding β€” latest first
Holder Aug 2026 Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Promoters 77.00 41.30 41.30 41.30 41.30 41.30 41.30 41.30 41.30 41.30 41.30 41.30
Public 23.00 58.70 58.72 58.72 58.72 58.71 58.70 58.70 58.70 58.71 58.71 58.70
No. of Shareholders 2,457 2,465 2,475 504 2,427 2,442 2,427 2,430 2,445 2,431 2,432 2,440

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Split 30 Apr 2014 02 May 2014 10:5 β€”

Announcements

5 filings